PRNewswire - Techseriesinsight

October 29, 2024
PRNewswire
Customer Experience

Cellcard Applauded by Frost & Sullivan for Offering Customers New Experiences, Convenience, and Value with a Significant Financial Impact in Mobile Services USA – English

Frost & Sullivan recently researched the mobile services industry and, based on its analysis, recognizes Cellcard with the 2024 Cambodian Customer Value Leadership Award. The company is a comprehensive digital lifestyle provider...

October 29, 2024
PRNewswire
Artificial Intelligence

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI USA – English

Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced today that it has raised $34 million in Series B financing. This additional funding...

October 29, 2024
PRNewswire
Artificial Intelligence

The Tianqiao & Chrissy Chen Institute’s OMNE Framework for Long-term AI Memory Claims Top Spot on GAIA Leaderboard

Drawing on their deep knowledge of the brain and memory, the Tianqiao & Chrissy Chen Institute’s (TCCI) internal AI team achieved a major breakthrough in artificial intelligence, with their...

October 29, 2024
PRNewswire
Networking

DriveNets and NESIC Join Forces to Expand Disaggregated, Cloud-Native Networking Solutions in Japan

DriveNets – a leader in innovative networking solutions – today announced it is collaborating with NEC Networks & System Integration Corporation (NESIC) to expand the availability of disaggregated cloud-native networking solutions in Japan....

October 28, 2024
PRNewswire
Biotechnology

WuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development

WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia™ RidGS, a high-yield glutamine synthetase (GS)-knockout Chinese hamster...

October 28, 2024
PRNewswire
Healthcare

Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 2025

Ottimo Pharma, a private biotech company, announces the appointment of world class industry veterans David Epstein as Chair & Chief Executive Officer, Mehdi Shahidi as Head of Development & Chief Medical Officer and James...

October 28, 2024
PRNewswire
Analytics

GO extends investment in Elisa Polystar’s KALIX solution portals, unlocking real-time analytics to enhance network quality and customer experience

GO, a leading provider of quad-play services in Malta, has signed a new agreement to increase its investment in Elisa Polystar’s network monitoring and analytics solutions. GO has long benefitted...

October 28, 2024
PRNewswire
Robotics

NaoTrac to Redefine Surgical Navigation Robotics at MEDICA 2024

NaoTrac, Brain Navi Biotechnology’s flagship autonomous surgical navigation robot, is set to take center stage at MEDICA 2024, the world’s largest medical trade fair, held in Düsseldorf, Germany, from November 11-14....

October 28, 2024
PRNewswire
Artificial Intelligence

Explore Wincomm’s Latest Innovations in Medical AI PCs at Medica 2024 USA – English

Wincomm, a global leader in medical computing solutions, is thrilled to announce its participation in Medica 2024, one of the world’s leading medical exhibitions. From November 11 to 14, 2024, attendees...

October 25, 2024
PRNewswire
Healthcare

Corvia Medical Announces Three-Year Clinical Trial Results Confirming Significant and Durable Benefits of the Corvia Atrial Shunt in Heart Failure Patients

Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced impressive three-year results from its REDUCE LAP-HF II randomized clinical trial confirming safety and...